Platte River Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Platte River Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2M	Hold	3,230	–	–	0.54%	36
2024 Q2	$1.79M	Sell	3,230 -125	-4%	-$71.6K	0.5%	39
2024 Q1	$1.95M	Sell	3,355 -5	-0.1%	-$2.81K	0.56%	35
2023 Q4	$1.78M	Hold	3,360	–	–	0.59%	36
2023 Q3	$1.7M	Hold	3,360	–	–	0.62%	33
2023 Q2	$1.75M	Buy	3,360 +115	+4%	+$62.1K	0.61%	33
2023 Q1	$1.87M	Sell	3,245 -170	-5%	-$95.8K	0.72%	32
2022 Q4	$1.88M	Sell	3,415 -145	-4%	-$76.8K	0.79%	31
2022 Q3	$1.81M	Hold	3,560	–	–	0.81%	31
2022 Q2	$1.93M	Sell	3,560 -10	-0.3%	-$5.5K	0.84%	29
2022 Q1	$2.11M	Sell	3,570 -76	-2%	-$43.7K	0.77%	28
2021 Q4	$2.26M	Sell	3,646 -68	-2%	-$42.5K	0.77%	30
2021 Q3	$2.12M	Buy	3,714 +65	+2%	+$35.7K	0.79%	29
2021 Q2	$1.84M	Hold	3,649	–	–	0.7%	31
2021 Q1	$1.72M	Buy	3,649 +211	+6%	+$101K	0.71%	29
2020 Q4	$1.76M	Buy	3,438 +10	+0.3%	+$4.69K	0.76%	30
2020 Q3	$1.51M	Buy	3,428 +25	+0.7%	+$10.3K	0.78%	30
2020 Q2	$1.3M	Buy	+3,403	New	+$1.14M	0.72%	33
2019 Q4	$1.1M	Buy	+3,498	New	+$1.06M	0.58%	43

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Platte River Wealth Advisors's TMO Position: Q3 2024 in Review

Platte River Wealth Advisors held its Thermo Fisher Scientific (TMO) position steady in Q3 2024 at 3,230 shares worth $2M. The position accounts for 0.54% of the portfolio, ranked #36.

Platte River Wealth Advisors first reported a position in TMO in Q4 2019 and has held it in 19 quarters since. The position peaked at $2.26M in Q4 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Platte River Wealth Advisors held 3,230 shares of Thermo Fisher Scientific worth $2M as of Q3 2024.
Platte River Wealth Advisors left its Thermo Fisher Scientific share count unchanged in Q3 2024.
Thermo Fisher Scientific made up 0.54% of Platte River Wealth Advisors's portfolio in Q3 2024, its #36 holding.
Platte River Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 19 quarters since.
Platte River Wealth Advisors's Thermo Fisher Scientific position peaked at $2.26M in Q4 2021.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Platte River Wealth Advisors's 13F filing for Q3 2024, filed 7 Oct 2024.